[Recombinant MMP-14 catalytic domain inducing the apoptosis of human osteoblastic SaOS-2 cells]

Li-Juan Guo1, Xiang-Hang Luo, Xin Su

  • 1Institute of Endocrinology and Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Abstract

Insights

Recombinant matrix metalloproteinase-14 (MMP-14) catalytic domain (RMC) activates proMMP-2 and induces apoptosis in osteoblast-like cells by inhibiting cell adhesion. This suggests MMP-14

Area of Science:

  • Biochemistry
  • Cell Biology
  • Extracellular Matrix Biology

Context:

  • Osteoblasts are crucial for bone health, relying on interactions with the extracellular matrix for survival.
  • Matrix metalloproteinases (MMPs) play roles in tissue remodeling, but their specific effects on osteoblast function require further elucidation.
  • Understanding MMP-14's direct impact on osteoblasts is key to deciphering bone homeostasis and pathology.

Purpose:

  • To directly investigate the effects of the recombinant MMP-14 catalytic domain (RMC) on human osteoblastic SaOS-2 cells.
  • To analyze RMC's influence on proMMP-2 activation, cell adhesion to Type I collagen, and apoptosis.

Summary:

  • RMC activated proMMP-2 secreted by SaOS-2 cells, an effect inhibited by EDTA.
  • RMC dose-dependently inhibited SaOS-2 cell adhesion to Type I collagen, also reversible by EDTA.
  • RMC induced SaOS-2 cell apoptosis in a dose-dependent manner, with EDTA blocking this effect.

Impact:

  • The catalytic activity of MMP-14 on matrix proteins contributes to apoptosis induction in osteoblasts.
  • Cell adhesion to the extracellular matrix is a survival mechanism for osteoblasts.
  • These findings highlight a novel mechanism by which MMP-14 may influence bone cell viability and function.